Prelude Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,495
| Closed | -$5K | – | 1949 |
|
|
2018
Q3 | $5K | Buy |
1,495
+1,489
| +24,817% | +$4.98K | ﹤0.01% | 1278 |
|
|
2018
Q2 | $0 | Sell |
6
-1,411
| -100% | – | ﹤0.01% | 1826 |
|
|
2018
Q1 | $6K | Buy |
1,417
+236
| +20% | +$999 | ﹤0.01% | 1256 |
|
|
2017
Q4 | $5K | Sell |
1,181
-10
| -0.8% | -$42 | ﹤0.01% | 1135 |
|
|
2017
Q3 | $8K | Sell |
1,191
-307
| -20% | -$2.06K | ﹤0.01% | 1336 |
|
|
2017
Q2 | $11K | Sell |
1,498
-20,011
| -93% | -$147K | ﹤0.01% | 1270 |
|
|
2017
Q1 | $132K | Buy |
+21,509
| New | +$132K | 0.01% | 654 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 2121 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 2209 |
|
|
2014
Q4 | – | Sell |
-5,000
| Closed | -$69K | – | 2167 |
|
|
2014
Q3 | $69K | Sell |
5,000
-200
| -4% | -$2.76K | 0.01% | 1173 |
|
|
2014
Q2 | $80K | Buy |
5,200
+3,800
| +271% | +$58.5K | 0.01% | 1065 |
|
|
2014
Q1 | $24K | Sell |
1,400
-126,100
| -99% | -$2.16M | ﹤0.01% | 1460 |
|
|
2013
Q4 | $1.65M | Buy |
127,500
+2,500
| +2% | +$32.4K | 0.27% | 58 |
|
|
2013
Q3 | $1.26M | Hold |
125,000
| – | – | 0.2% | 73 |
|
|
2013
Q2 | $934K | Buy |
+125,000
| New | +$934K | 0.2% | 94 |
|